• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物材料的清除动力学影响干细胞的保留和治疗效果。

Clearance kinetics of biomaterials affects stem cell retention and therapeutic efficacy.

机构信息

Institute of Biomedical Sciences, Academia Sinica , No. 128 Sec. 2, Academia Road, Taipei 115, Taiwan.

出版信息

Biomacromolecules. 2014 Feb 10;15(2):564-73. doi: 10.1021/bm401583b. Epub 2014 Jan 6.

DOI:10.1021/bm401583b
PMID:24372561
Abstract

The use of biomaterial carriers to improve the therapeutic efficacy of stem cells is known to augment cell delivery, retention, and viability. However, the way that carrier clearance kinetics boosts stem cell delivery and impacts stem cell function remains poorly characterized. In this study, we designed a platform to simultaneously quantify carrier clearance and stem cell retention to evaluate the impact of carrier clearance kinetics on stem cell retention. Additionally, a murine model of hindlimb ischemia was employed to investigate the effects of various cell retention profiles on mitigating peripheral arterial disease. To image the in vivo behaviors of material and cells, we used biotinylated hyaluronan with fluorescently labeled streptavidin and Discosoma sp. Red (Ds-Red)-expressing human mesenchymal stem cells. We found that the retention of transplanted stem cells was closely related to the remaining biomaterial. Furthermore, therapeutic effectiveness was also affected by stem cell retention. These results demonstrate that low-molecular-weight hyaluronan had a slow clearance and high cell retention profile, improving the therapeutic efficacy of human stem cells.

摘要

利用生物材料载体来提高干细胞的治疗效果已被证实可以增加细胞的递送、保留和活力。然而,载体清除动力学如何促进干细胞的递送以及影响干细胞功能仍未得到很好的描述。在本研究中,我们设计了一个平台来同时定量载体清除和干细胞保留,以评估载体清除动力学对干细胞保留的影响。此外,我们还利用后肢缺血的小鼠模型来研究不同的细胞保留曲线对减轻外周动脉疾病的影响。为了在体内可视化材料和细胞的行为,我们使用了带有荧光标记链霉亲和素的生物素化透明质酸和表达 Discosoma sp. Red (Ds-Red) 的人骨髓间充质干细胞。我们发现,移植干细胞的保留与剩余的生物材料密切相关。此外,治疗效果也受到干细胞保留的影响。这些结果表明,低分子量透明质酸具有缓慢的清除和高细胞保留特性,从而提高了人源干细胞的治疗效果。

相似文献

1
Clearance kinetics of biomaterials affects stem cell retention and therapeutic efficacy.生物材料的清除动力学影响干细胞的保留和治疗效果。
Biomacromolecules. 2014 Feb 10;15(2):564-73. doi: 10.1021/bm401583b. Epub 2014 Jan 6.
2
Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.过表达端粒酶和心肌营养素的间充质细胞移植促进了小鼠后肢缺血模型中的血管生成和组织修复。
Circ Res. 2013 Sep 13;113(7):902-14. doi: 10.1161/CIRCRESAHA.113.301690. Epub 2013 Jun 18.
3
The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan.利用透明质酸增强内皮细胞疗法在下肢缺血中的血管生成作用。
Biomaterials. 2011 Jan;32(1):75-86. doi: 10.1016/j.biomaterials.2010.08.085.
4
Enhancing Therapeutic Efficacy and Reducing Cell Dosage in Stem Cell Transplantation Therapy for Ischemic Limb Diseases by Modifying the Cell Injection Site.通过改变细胞注射部位提高缺血性肢体疾病干细胞移植治疗的疗效并减少细胞剂量
Tissue Eng Part A. 2016 Feb;22(3-4):349-62. doi: 10.1089/ten.tea.2015.0119. Epub 2016 Jan 29.
5
Three-dimensional cell aggregates composed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia.由 HUVECs 和 cbMSCs 组成的三维细胞聚集体用于治疗小鼠后肢缺血模型中的新血管生成。
Biomaterials. 2013 Mar;34(8):1995-2004. doi: 10.1016/j.biomaterials.2012.11.045. Epub 2012 Dec 12.
6
Delivery of fibroblast growth factor 2 enhances the viability of cord blood-derived mesenchymal stem cells transplanted to ischemic limbs.成纤维细胞生长因子 2 的递送可提高移植至缺血肢体的脐带血间充质干细胞的活力。
J Biosci Bioeng. 2011 May;111(5):584-9. doi: 10.1016/j.jbiosc.2011.01.003. Epub 2011 Mar 8.
7
Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia.羊膜间充质干细胞具有强大的血管生成特性,在治疗后肢缺血方面非常有效。
Cardiovasc Res. 2012 Mar 1;93(3):525-34. doi: 10.1093/cvr/cvr328. Epub 2011 Dec 12.
8
Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment.注射用水凝胶增强间充质干细胞衍生外泌体治疗后肢缺血的疗效。
ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30081-30091. doi: 10.1021/acsami.8b08449. Epub 2018 Aug 29.
9
Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.增强型人骨髓间充质干细胞治疗性血管生成在小鼠后肢缺血模型中的作用。
Regen Med. 2013 May;8(3):283-93. doi: 10.2217/rme.13.17.
10
Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.低氧骨髓间充质干细胞移植可改善同种异体受体肢体缺血。
Cardiovasc Res. 2014 Feb 1;101(2):266-76. doi: 10.1093/cvr/cvt250. Epub 2013 Nov 12.

引用本文的文献

1
Systems Approaches to Cell Culture-Derived Extracellular Vesicles for Acute Kidney Injury Therapy: Prospects and Challenges.系统方法用于细胞培养衍生的细胞外囊泡治疗急性肾损伤:前景与挑战。
Function (Oxf). 2024 Mar 28;5(3):zqae012. doi: 10.1093/function/zqae012. eCollection 2024.
2
Degradable Biocompatible Porous Microtube Scaffold for Extended Donor Cell Survival and Activity.可降解生物相容性多孔微管支架,用于延长供体细胞的存活和活性。
ACS Biomater Sci Eng. 2023 Feb 13;9(2):719-731. doi: 10.1021/acsbiomaterials.2c00899. Epub 2023 Jan 3.
3
Stem cell-based regenerative medicine.
基于干细胞的再生医学。
Stem Cell Investig. 2019 Jul 18;6:19. doi: 10.21037/sci.2019.06.04. eCollection 2019.
4
Multimodal Hydrogel-Based Platform To Deliver and Monitor Cardiac Progenitor/Stem Cell Engraftment.用于递送和监测心脏祖细胞/干细胞植入的基于多模态水凝胶的平台
ACS Cent Sci. 2017 Apr 26;3(4):338-348. doi: 10.1021/acscentsci.7b00039. Epub 2017 Mar 30.
5
Injection of Human Cord Blood Cells With Hyaluronan Improves Postinfarction Cardiac Repair in Pigs.注射含透明质酸的人脐带血细胞可改善猪心肌梗死后的心脏修复。
Stem Cells Transl Med. 2016 Jan;5(1):56-66. doi: 10.5966/sctm.2015-0092. Epub 2015 Nov 16.
6
Label-free imaging of gelatin-containing hydrogel scaffolds.含明胶水凝胶支架的无标记成像。
Biomaterials. 2015 Feb;42:144-50. doi: 10.1016/j.biomaterials.2014.11.050. Epub 2014 Dec 16.